Brainstorm Announces Milestone Towards ALS Clinical Trials Posted on: October 5, 2009 Brainstorm Cell Therapeutics, a competitor for Prize4Life's Avi Kremer ALS Treatment Prize, announced that bone marrow cells taken from ALS patients are capable of differentiating into nerve-supporting cells. Read the Business Wire press release here.